Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00424424 |
This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in male patients.
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
Condition | Intervention | Phase |
---|---|---|
Pain, Postoperative |
Drug: MK0719 |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Dose Comparison, Single Group Assignment, Efficacy Study |
Official Title: | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria :
Exclusion Criteria :
Study ID Numbers: | 2007_505 |
Study First Received: | January 18, 2007 |
Last Updated: | April 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00424424 |
Health Authority: | United States: Food and Drug Administration |
Postoperative Dental Pain |
Signs and Symptoms Postoperative Complications Toothache Pain Pain, Postoperative |
Pathologic Processes |